2 completed, 2 unknown, 1 active not recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow SCM Lifescience Co., LTD.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical Trials Not Applicable (Observational Study) - Dermatitis, Atopic | Unknown | SCM Lifescience Co., LTD. | 92 | 2020-08-25 | 2021-03-17 | |
| Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis SCM-AGH, Placebo - Dermatitis, Atopic | Phase 1 / Phase 2 | Completed | SCM Lifescience Co., LTD. | 92 | 2020-03-24 | 2023-06-08 |
| Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis SCM-AGH, Placebo - Pancreatitis, Acute | Phase 1 / Phase 2 | Completed | SCM Lifescience Co., LTD. | 36 | 2019-08-12 | 2023-06-08 |
| A Long-term Safety Follow-up Study of SCM-AGH in Patients Who Completed SCM-APT2001 Study Not Applicable(Observation Study) - Pancreatitis, Acute | Active not recruiting | SCM Lifescience Co., LTD. | 42 | 2019-05-10 | 2023-11-28 | |
| Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease SCM-CGH, Placebo - Chronic Graft-versus-host-disease | Phase 2 | Unknown | SCM Lifescience Co., LTD. | 84 | 2016-09-28 | 2023-06-08 |
Dermatitis, Atopic (2) · Pancreatitis (2) · Bronchiolitis Obliterans Syndrome (1)
Observation (1)
South Korea (5)
Gwang Seong Choi, MD-Ph.D (2) · Yun Nah Lee (1)